We are live on ! Find out more
MIM

Marco Investment Management Portfolio holdings

AUM $1.52B
1-Year Est. Return 47.33%
This Fund
S&P 500
This Quarter Est. Return
-13.62%
1 Year Est. Return
+47.33%
3 Year Est. Return
+126.67%
5 Year Est. Return
+163.42%
10 Year Est. Return
+1,200.89%
AUM
$859M
AUM Growth
-$126M
Cap. Flow
+$22.5M
Cap. Flow %
2.62%
Top 10 Hldgs %
30.91%
Holding
217
New
7
Increased
87
Reduced
58
Closed
19

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$7.11M
2
GS icon
Goldman Sachs
GS
+$4.76M
3
QCOM icon
Qualcomm
QCOM
+$2.99M
4
LRCX icon
Lam Research
LRCX
+$2.86M
5
MSFT icon
Microsoft
MSFT
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 29.64%
2 Healthcare 18.99%
3 Industrials 10.01%
4 Financials 8.55%
5 Consumer Staples 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLAC icon
26
KLA
KLAC
$259B
$10.1M 1.17%
315,400
+11,550
+4% +$388K
AXP icon
27
American Express
AXP
$230B
$9.3M 1.08%
67,106
+3,600
+6% +$595K
MDT icon
28
Medtronic
MDT
$112B
$9.14M 1.06%
101,879
-500
-0.5% -$50.7K
PG icon
29
Procter & Gamble
PG
$339B
$9.09M 1.06%
63,199
+775
+1% +$116K
CRM icon
30
Salesforce
CRM
$158B
$8.84M 1.03%
53,583
+1,924
+4% +$340K
MRK icon
31
Merck
MRK
$318B
$8.78M 1.02%
96,302
+2,482
+3% +$220K
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$8.75M 1.02%
23,183
-350
-1% -$143K
PFE icon
33
Pfizer
PFE
$153B
$8.23M 0.96%
157,066
+8,742
+6% +$445K
ABT icon
34
Abbott
ABT
$187B
$7.91M 0.92%
72,788
+85
+0.1% +$9.65K
ORCL icon
35
Oracle
ORCL
$423B
$7.84M 0.91%
112,204
+65
+0.1% +$4.76K
NOC icon
36
Northrop Grumman
NOC
$81.2B
$7.52M 0.88%
15,717
+133
+0.9% +$61.1K
GOOGL icon
37
Alphabet (Google) Class A
GOOGL
$4.33T
$7.3M 0.85%
67,040
+1,160
+2% +$137K
COP icon
38
ConocoPhillips
COP
$141B
$7.25M 0.84%
80,712
-256
-0.3% -$26.4K
DIS icon
39
Walt Disney
DIS
$181B
$7.14M 0.83%
75,640
+2,434
+3% +$270K
PANW icon
40
Palo Alto Networks
PANW
$297B
$7.09M 0.83%
86,154
+240
+0.3% +$21.3K
MGA icon
41
Magna International
MGA
$18.8B
$7.04M 0.82%
128,225
+1,200
+0.9% +$73.1K
TMO icon
42
Thermo Fisher Scientific
TMO
$220B
$6.94M 0.81%
12,771
-200
-2% -$110K
LRCX icon
43
Lam Research
LRCX
$390B
$6.83M 0.8%
160,390
+60,000
+60% +$2.86M
HON icon
44
Honeywell
HON
$78B
$6.41M 0.75%
39,122
+869
+2% +$156K
AMD icon
45
Advanced Micro Devices
AMD
$789B
$6.33M 0.74%
82,822
+20,000
+32% +$1.87M
LHX icon
46
L3Harris
LHX
$53.4B
$6.11M 0.71%
25,273
-85
-0.3% -$20.5K
PSX icon
47
Phillips 66
PSX
$81.4B
$6.1M 0.71%
74,346
-86
-0.1% -$7.96K
JNJ icon
48
Johnson & Johnson
JNJ
$625B
$5.95M 0.69%
33,521
-6
-0% -$1.07K
DUK icon
49
Duke Energy
DUK
$97.3B
$5.7M 0.66%
53,170
+1,700
+3% +$187K
AFL icon
50
Aflac
AFL
$62.6B
$5.53M 0.64%
99,937
-403
-0.4% -$23.8K

Similar funds

Marco Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Marco Investment Management held 217 positions worth $859M, down 13% from $985M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Marco Investment Management's Q2 2022 filing shows 7 new, 87 increased, 58 reduced and 19 closed positions. Its largest new stake was Woodside Energy: 15,159 shares worth $327K. The largest sale was Illumina, an estimated $3.95M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Marco Investment Management's largest Q2 2022 buy was Woodside Energy: 15,159 shares worth $327K.
  • Marco Investment Management added most to Broadcom in Q2 2022, an estimated $7.11M increase.
  • Marco Investment Management's biggest Q2 2022 reduction was iShares Biotechnology ETF, cutting an estimated $3.5M.
  • Marco Investment Management fully exited Illumina in Q2 2022, selling an estimated $3.95M.
  • Marco Investment Management's ten largest holdings make up 31% of its $859M portfolio in Q2 2022.
  • Marco Investment Management opened 7 new positions and closed 19 in Q2 2022.
  • Marco Investment Management's portfolio value fell 13% quarter-over-quarter to $859M.

Based on Marco Investment Management's 13F filing for Q2 2022, filed 5 Aug 2022.